视神经脊髓炎谱系疾病全球发病率与患病率系统综述
该系统综述检索1999年至2019年8月PubMed、Ovid MEDLINE和Embase数据库,纳入33篇相关文章,评估全球视神经脊髓炎谱系疾病(NMOSD)的患病率、发病率及人口学特征。结果显示非洲-加勒比地区发病率和患病率最高(0.73/10万人年,95%CI 0.45-1.01;10/10万人,95%CI 6.8-13.2),澳大利亚和新西兰最低(0.037/10万人年,95%CI 0.036-0.038;0.7/10万人,95%CI 0.66-0.74)。成人及AQP4抗体阳性亚群以女性为主,发病率和患病率在中青年达峰,非洲裔最高、白种人最低,发病率无显著时间趋势。
要点
- 全球NMOSD为罕见病,不同地区和种族间发病率与患病率存在差异。
- 非洲-加勒比地区发病率与患病率最高,澳大利亚和新西兰最低。
- 成人及AQP4抗体阳性者女性占优势,发病率和患病率在中青年达峰。
核心结论
- NMOSD全球罕见,患病率和发病率在不同地理区域和种族间存在差异,这些差异仅部分由研究方法和定义不同解释。
研究设计与样本
- 系统综述检索PubMed、Ovid MEDLINE和Embase数据库(1999年至2019年8月),纳入33篇相关文章,收集发病率、患病率及年龄、性别、种族特异性数据。
主要发现
- 非洲-加勒比地区发病率最高为0.73/10万人年(95%CI 0.45-1.01),患病率最高为10/10万人(95%CI 6.8-13.2)。
- 澳大利亚和新西兰发病率最低为0.037/10万人年(95%CI 0.036-0.038),患病率最低为0.7/10万人(95%CI 0.66-0.74)。
- 成人及AQP4抗体血清阳性亚群中女性占优势,发病率和患病率在中青年达峰。
- 非洲裔发病率和患病率最高,白种人最低,发病率无显著时间趋势。
临床怎么用
- 临床需结合地区与种族流行病学特征,对中青年女性及AQP4抗体阳性者保持对NMOSD的警惕。
局限性
- 患病率和发病率的差异仅部分由研究方法和NMO/NMOSD定义不同解释,需专门设计的流行病学研究识别遗传与病因因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Since the last epidemiologic review of neuromyelitis optica/neuromyelitis optica spectrum disorder (NMO/NMOSD), 22 additional studies have been conducted. We systematically review the worldwide prevalence, incidence, and basic demographic characteristics of NMOSD and provide a critical overview of studies. METHODS: PubMed, Ovid MEDLINE, and Embase using Medical Subject Headings and keyword search terms and reference lists of retrieved articles were searched from 1999 until August 2019. We collected data on the country; region; methods of case assessment and aquaporin-4 antibody (AQP4-Ab) test; study period; limitations; incidence (per 100,000 person-years); prevalence (per 100,000 persons); and age-, sex-, and ethnic group-specific incidence or prevalence. RESULTS: We identified 33 relevant articles. The results indicated the highest estimates of incidence and prevalence of NMOSD in Afro-Caribbean region (0.73/100 000 person-years [95% CI: 0.45-1.01] and 10/100 000 persons [95% CI: 6.8-13.2]). The lowest incidence and prevalence of NMOSD were found in Australia and New Zealand (0.037/100 000 person-years [95% CI: 0.036-0.038] and 0.7/100,000 persons [95% CI: 0.66-0.74]). There was prominent female predominance in adults and the AQP4-Ab-seropositive subpopulation. The incidence and prevalence peaked in middle-aged adults. African ethnicity had the highest incidence and prevalence of NMOSD, whereas White ethnicity had the lowest. No remarkable trend of incidence was described over time. CONCLUSION: NMOSD is a rare disease worldwide. Variations in prevalence and incidence have been described among different geographic areas and ethnicities. These are only partially explained by different study methods and NMO/NMOSD definitions, highlighting the need for specifically designed epidemiologic studies to identify genetic effects and etiologic factors.
引用
- Papp V, Magyari M, Aktas O, et al. Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review. Neurology. 2020. PMID: 33310876. doi:10.1212/WNL.0000000000011153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。